Navigation Links
Pharma IQ's Pharma CTS Europe Infographic
Date:8/24/2012

LONDON, August 24, 2012 /PRNewswire/ --

Pharma IQ has just published the results of an industry wide clinical trials survey, conducted recently among 4,500 clinical specialists with over 40% located in Europe.

Over a third of the clinical trial supply respondents to our recent survey said that outsourcing distribution and logistics was their main priority for the investment this year, whereas cool chain technologies was mentioned by 27%. Quarter of the respondents will focus on the supply chains in emerging markets. Other concerns included IVRS technology, labelling technologies and outsourcing.  Added to this, the number of clinical trials to be conducted in the BRIC region in 2013 is predicted to increase to 70.7%.

Pharma IQ also asked the respondents about the top areas for improvement in the clinical trial supply. Understanding GDP regulations and designing a supply chain for adaptive clinical trials were the most common issues closely followed by a just-in-time labelling strategy and computer sourcing.

The infographic is available to download at http://www.clinicalsupplyeurope.com/news.

The survey was created as a part of the pre-conference research for Clinical Trial Supply, taking place 30 January-01 February 2013.

The results helped to shape the CTS Online Library consisting of regularly updated presentations, speaker Interviews and presentations coordinated with the IQPC clinical trials event.

0ther content available in CTS Online Library includes:

- Interview with Robert Smith, former Director, Clinical Pharmacy Research Services at Genzyme. Mr Smith discusses the latest approaches and tools to ensure flexibility of clinical supplies. He talks about the use of IRT, removing expiry dates and pooling supplies all with a view to reducing waste and making efficiency improvements. There is also an overview of the role of BRIC countries in the next few years and the need to improve communication between East and West for successful collaborations.

- Article: Talking Heads: 7 Growing Trends in Clinical Trial Supply

Pharma IQ had a quick ring around with some of our trusted experts who are working in clinical trials to get an overview on current and emerging trends in clinical trials

- Infographic: A Picture of Clinical Trial Supply Asia

An overview of the clinical trial industry in Asia trying to answer the questions of the expected growth in Clinical Trials in Asia.

To access the CTS Online Library or to find out more about Clinical Trial Supply Europe 2013 please visit http://www.clinicalsupplyeurope.com/news, email enquire@iqpc.co.uk or call +44(0)-2073689421.

Media contact: Joanna, +44-(0)20-7368-9807, joanna.checinska@iqpc.co.uk - Please contact for more information or images.

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (jaonna.checinska@iqpc.co.uk)


'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharma IQs Drug Recalls Industry Outline
2. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
3. Informex Global Pharma Sourcing 2012 Presents Key Strategies & Insight For Business Success
4. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
5. Actinium Pharmaceuticals Strengthens Management Team
6. A Slow Economy and High Development Costs to Drive Rise in Pharmaceutical Outsourcing to Contract Research Organizations
7. iPads Transforming How Pharma Sales Forces Interact with Physicians & Payers
8. Med Ad News, PharmaLive and Pharmalot Announce the Pharma Interactive Conference in Princeton, NJ
9. BioWorld Launches Enhanced Biopharma News Site with Data, Analysis
10. Pharma Manufacturing & Quality Management China 2012 is Upcoming
11. Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):